You are adding an alert for:
Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista®), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD).
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: